Management of pediatric hepatocellular carcinoma: A multimodal approach.

about

Hepatocellular carcinoma in children: hepatic resection and liver transplantation

P2860

Q58555478-8E037B0B-6D80-42FE-A68A-D86491557F9A

P2860

Management of pediatric hepatocellular carcinoma: A multimodal approach.

Item

http://www.wikidata.org/entity/Q48252418

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Management of pediatric hepatocellular carcinoma: A multimodal approach.

@en

Management of pediatric hepatocellular carcinoma: A multimodal approach.

@nl

type

Item

label

Management of pediatric hepatocellular carcinoma: A multimodal approach.

@en

Management of pediatric hepatocellular carcinoma: A multimodal approach.

@nl

prefLabel

Management of pediatric hepatocellular carcinoma: A multimodal approach.

@en

Management of pediatric hepatocellular carcinoma: A multimodal approach.

@nl

P1476

Management of pediatric hepatocellular carcinoma: A multimodal approach

@en

P2093

Carola A S Arndt

http://www.w3.org/2001/XMLSchema#string

Deepti M Warad

http://www.w3.org/2001/XMLSchema#string

Jane M Matsumoto

http://www.w3.org/2001/XMLSchema#string

Julie K Heimbach

http://www.w3.org/2001/XMLSchema#string

Mira A Kohorst

http://www.w3.org/2001/XMLSchema#string

Mounif El-Youssef

http://www.w3.org/2001/XMLSchema#string

Vilmarie Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group

A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.

Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation.

First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.

Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database.

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

Rapamycin: an anti-cancer immunosuppressant?

Long-term outcome after liver transplantation in children.

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.

Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.

P31

scholarly article

P356

10.1111/PETR.13007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amulya A Nageswara Rao

P577

2017-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28631359

http://www.w3.org/2001/XMLSchema#string

Management of pediatric hepatocellular carcinoma: A multimodal approach.

about

P2860

P2860

Management of pediatric hepatocellular carcinoma: A multimodal approach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698